LBF20107PG21: Difference between revisions
No edit summary |
No edit summary |
||
| Line 11: | Line 11: | ||
|Chemical Synthesis= | |Chemical Synthesis= | ||
|Metabolism= | |Metabolism= | ||
|Biological Activity= | |Biological Activity=6beta-PGI1 has a Kact for adenylate cyclase in NCB-20 cells of 4.2 muM compared with 18 nM for PGI2.[[Reference:Whittle_BJ:Moncada_S:Whiting_F:Vane_JR:,Prostaglandins,1980,19,605|{{RelationTable/GetFirstAuthor|Reference:Whittle_BJ:Moncada_S:Whiting_F:Vane_JR:,Prostaglandins,1980,19,605}}]] | ||
}} | }} | ||
{{Lipid/Footer}} | {{Lipid/Footer}} | ||
Revision as of 23:00, 19 February 2010
| LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
| IDs and Links | |
|---|---|
| LipidBank | XPR1800 |
| LipidMaps | LMFA03010129 |
| CAS | |
| KEGG | {{{KEGG}}} |
| KNApSAcK | {{{KNApSAcK}}} |
| mol | LBF20107PG21 |
| 6β-Prostaglandin I1 | |
|---|---|
| |
| Structural Information | |
| 6S,9α-epoxy-11α,15S-dihydroxy-prost-13E-en-1-oic acid | |
| |
| Formula | C20H34O5 |
| Exact Mass | 354.240624198 |
| Average Mass | 354.48096000000004 |
| SMILES | C(CC[C@H](O)C=C[C@H]([C@H]12)[C@H](O)C[C@H](O[C@H](C2)CCCCC(O)=O)1)CC |
| Physicochemical Information | |
| 6beta-PGI1 has a Kact for adenylate cyclase in NCB-20 cells of 4.2 muM compared with 18 nM for PGI2. Whittle_BJ et al. | |
| Spectral Information | |
| Mass Spectra | |
| UV Spectra | |
| IR Spectra | |
| NMR Spectra | |
| Other Spectra | |
| Chromatograms | |
| Reported Metabolites, References | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
